Wheat Dextrin (Benefiber)
Soluble wheat dextrin
A tasteless, fully soluble wheat fiber (Benefiber) with real prebiotic and glycemic effects but little proof it relieves constipation.
Evidence tier
Moderate
Research weight
Citations
8 verified / 8
Classification
Prebiotics & Fibers
❝
What the evidence says. Several controlled trials; effects real but modest or context-dependent.
What is Wheat Dextrin (Benefiber)?
Wheat Dextrin (Benefiber) (Soluble wheat dextrin) is a prebiotic fiber used for acts as a prebiotic: fermented in the colon to short-chain fatty acids (butyrate, propionate) and shifts the microbiota, including increasing parabacteroides distasonis and bifidobacteria-type changes. NutriDex grades the human evidence as Moderate. Wheat dextrin is a soluble, non-viscous, highly fermentable fiber made by heat- and acid-treating wheat starch; it is the active ingredient in Benefiber and is closely related to the resistant dextrin NUTRIOSE used in most clinical trials. The strongest randomized-trial evidence is metabolic: meta-analyses show modest improvements in fasting glucose and insulin resistance (HOMA-IR), and it acts as a genuine prebiotic, shifting the gut microbiota and raising short-chain fatty acids. Importantly, despite being marketed for regularity, wheat dextrin is non-viscous and has essentially no water-holding capacity, so controlled evidence that it relieves constipation or increases stool output is weak to absent, unlike psyllium. It is very well tolerated up to roughly 30-45 g/day, with gas being the main dose-limiting effect.
Purported Benefits
✓Acts as a prebiotic: fermented in the colon to short-chain fatty acids (butyrate, propionate) and shifts the microbiota, including increasing Parabacteroides distasonis and bifidobacteria-type changes
✓Improves insulin resistance: in women with type 2 diabetes, 10 g/day for 8 weeks lowered HOMA-IR by ~25% and fasting insulin by ~23% versus placebo
✓Lowers fasting blood glucose modestly across RCTs (pooled WMD -0.15 mmol/L), with the largest benefit in people with type 2 diabetes or overweight/obesity
✓Reduces inflammatory and metabolic-endotoxemia markers (IL-6, TNF-alpha, endotoxin) in trials in type 2 diabetes
✓Increases satiety and blunts postprandial insulin and glucose responses when taken with a meal, supporting appetite/weight management
✓Honest caveat: unlike psyllium, it is non-viscous with no water-holding capacity, so it has little proven benefit for constipation, stool bulk, or LDL cholesterol lowering
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Improves insulin resistance (HOMA-IR)Meta-analysis (WMD HOMA-IR -0.51) plus a T2D RCT showing ~25% HOMA-IR drop; effect clearest in diabetic populations. | Moderate | ↑ benefit · moderate | 2 |
| Lowers fasting blood glucosePooled WMD only -0.15 mmol/L (CI touches zero); real but small, concentrated in T2D/overweight. | Moderate | ↑ benefit · small | 2 |
| Prebiotic microbiota shift / raises SCFARCT shows increased Parabacteroides distasonis; in-vitro butyrate rise. Genuine prebiotic signal but limited human SCFA data. | Moderate | ↑ benefit · moderate | 2 |
| Lowers inflammatory markers (IL-6, TNF-a, endotoxin)Single T2D RCT (n=55) reduced IL-6, TNF-alpha and endotoxin; not yet replicated. | Preliminary | ↑ benefit · moderate | 1 |
| Increases satiety / blunts postprandial glucoseOne RCT in healthy adults showed greater satiety and improved postprandial GLP-1/glucose at ~7.5-14 g/day. | Preliminary | ↑ benefit · small | 1 |
| Relieves constipation / increases stool outputNon-viscous, no water-holding capacity; authoritative review concludes it is not an effective laxative despite marketing. | Moderate | — no effect · negligible | 1 |
Dosing & Compounds
Typical Dose
Common label dose is ~3-5 g (about 1-2 teaspoons / one packet) up to ~3 times daily, dissolved in water or soft food; it is tasteless and dissolves clear. Trials of resistant dextrin for metabolic benefit typically use 10-15 g/day; tolerance studies show 30-45 g/day is well tolerated long term. Start low and increase gradually to limit gas.
Active Compounds
Safety & Cautions
Generally very well tolerated; the main side effects are flatulence, bloating, and abdominal discomfort because it is fully fermentable (a FODMAP-type, gas-producing fiber). Long-term doses of 30-45 g/day were well tolerated in healthy men, but higher acute doses (60-80 g/day) clearly increase flatulence versus placebo, and people with IBS may be more sensitive to gas. Contains wheat-derived material; although highly processed and typically very low in gluten, people with celiac disease or wheat allergy should choose a verified gluten-free product or avoid it. As with any fiber, take with adequate fluid and separate from medications by ~2-4 hours, since fiber can delay or reduce absorption of co-ingested drugs. It does NOT carry the choking/esophageal-obstruction hazard of bulk-forming gel fibers like psyllium or glucomannan because it is non-viscous, but it should not be relied on as a primary constipation treatment. People with diabetes on glucose-lowering medication should monitor blood sugar. Educational only — always check with your doctor or pharmacist before combining Wheat Dextrin (Benefiber) with any medicine.
Key Studies
Systematic review and meta-analysis of RCTs
Chen et al. 2026 (13 RCTs, 952 participants)
✓ Full text
Resistant dextrin significantly lowered fasting blood glucose (WMD -0.15 mmol/L, 95% CI -0.30 to 0.00) and HOMA-IR (WMD -0.51, 95% CI -0.93 to -0.09), with non-significant trends for HbA1c (-0.18%) and fasting insulin.
Randomized controlled trial
Thirion et al. 2022 (RCT, fecal microbiome)
✓ Source
NUTRIOSE resistant dextrin supplementation significantly increased the abundance of the beneficial gut bacterium Parabacteroides distasonis in healthy adults, demonstrating a prebiotic microbiota shift.
Randomized controlled trial
Hobden et al. 2021 (RCT, n=histy adults)
✓ Full text
~7.5-14 g/day resistant dextrin increased fasting satiety and improved postprandial glycemic and incretin (GLP-1) responses in healthy adults versus control.
Randomized controlled trial
Aliasgharzadeh et al. 2015 (n=55 women with T2D)
✓ PubMed
10 g/day resistant dextrin for 8 weeks reduced HOMA-IR by ~24.9%, fasting insulin by ~22.8%, and IL-6, TNF-alpha and endotoxin versus maltodextrin placebo (all P<0.05).
Randomized double-blind tolerance trial
Guerin-Deremaux et al. 2010 (tolerance RCT)
✓ Source
In healthy men, wheat dextrin (NUTRIOSE FB10) increased flatulence versus placebo at acute doses of 60-80 g/day, defining the upper tolerance threshold for this fermentable fiber.
Randomized double-blind tolerance trial
Pasman et al. 2006 (long-term tolerance RCT)
✓ PubMed
Daily intake of 30 or 45 g NUTRIOSE FB wheat dextrin for 4-5 weeks was well tolerated, with gastrointestinal complaints barely differing from placebo.
Evidence-based narrative review
McRorie & Fahey 2017 (review of fiber physics)
✓ Source
Wheat dextrin is a non-viscous, readily fermented soluble fiber with no water-holding capacity, so it does not increase stool output and is not an effective laxative despite marketing for regularity.
In vitro fermentation study
Hobden et al. 2013 (in vitro colonic model)
✓ Source
Fermentation of NUTRIOSE FB06 wheat dextrin in a continuous human colonic culture model increased beneficial bacteria and short-chain fatty acid (notably butyrate) production.